Please use this identifier to cite or link to this item: http://docs.prosentient.com.au/prosentientjspui/handle/1/13165
Title: Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical Register.
Authors: Maple-Brown, Louise J
Lindenmayer, Greta
Barzi, Federica
Whitbread, Cherie
Connors, Christine
Moore, Elizabeth
Boyle, Jacqueline
Kirkwood, Marie
Lee, I-Lynn
Longmore, Danielle
van Dokkum, Paula
Wicks, Mary
Dowden, Michelle
Inglis, Chrissie
Cotter, Margaret
Kirkham, Renae
Corpus, Sumaria
Chitturi, Sridhar
Thomas, Sujatha
O'Dea, Kerin
Zimmet, Paul
Oats, Jeremy
McIntyre, Harold D
Brown, Alex
Shaw, Jonathan E
Journal Title: Journal of diabetes
metadata.dc.description.affiliation: Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Darwin, Northern Territory, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Northern Territory Department of Health, Darwin, Northern Territory, Australia.
Aboriginal Medical Services Alliance Northern Territory, Darwin, Northern Territory, Australia.
Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Department of Medicine, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
Population Health Research, Baker Heart and Diabetes Institute, Alice Springs, Northern Territory, Australia.
One Disease, Darwin, Northern Territory, Australia.
Healthy Living NT, Darwin, Northern Territory, Australia.
Danila Dilba Health Service, Darwin, Northern Territory, Australia.
Obstetrics and Gynaecology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Population Health Research, University of South Australia, Adelaide, South Australia, Australia.
Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Mater Medical Research Institute, University of Queensland, Brisbane, Queensland, Australia.
South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Population Health Research, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Abstract: BACKGROUND: In Australia's Northern Territory, Indigenous mothers account for 33% of births and have high rates of hyperglycemia in pregnancy. The prevalence of type 2 diabetes (T2D) in pregnancy is up to 10-fold higher in Indigenous than non-Indigenous Australian mothers, and the use of metformin is common. We assessed birth outcomes in relation to metformin use during pregnancy from a clinical register. METHODS: The study included women with gestational diabetes (GDM), newly diagnosed diabetes in pregnancy (DIP), or pre-existing T2D from 2012 to 2016. Data were analyzed for metformin use in the third trimester. Regression models were adjusted for maternal age, body mass index, parity, and insulin use. RESULTS: Of 1649 pregnancies, 814 (49.4%) were to Indigenous women, of whom 234 (28.7%) had T2D (vs 4.6% non-Indigenous women; P < 0.001). Metformin use was high in Indigenous women (84%-90% T2D, 42%-48% GDM/DIP) and increased over time in non-Indigenous women (43%-100% T2D, 14%-35% GDM/DIP). Among Indigenous women with GDM/DIP, there were no significant differences between groups with and without metformin in cesarean section (51% vs 39%; adjusted odds ratio [aOR] 1.25, 95% confidence interval [CI] 0.87-1.81), large for gestational age (24% vs 13%; aOR 1.5, 95% CI 0.9-2.5), or serious neonatal adverse events (9.4% vs 5.9%; aOR 1.32, 95% CI 0.68-2.57). Metformin use was independently associated with earlier gestational age (37.7 vs 38.5 weeks), but the risk did not remain independently higher after exclusion of women managed with medical nutrition therapy alone, and the increase in births <37 weeks was not significant on multivariate analysis. CONCLUSIONS: We found no clear evidence of any adverse outcomes related to the use of metformin for the treatment of hyperglycemia in pregnancy.
URI: 
DOI: 10.1111/1753-0407.12905 [doi]
Type: Journal Article
Observational Study
Subjects: Adult
Australia/epidemiology
Biomarkers/*blood
Birth Weight
Blood Glucose/metabolism
Case-Control Studies
Diabetes Mellitus, Type 2/blood/*drug therapy/epidemiology
Diabetes, Gestational/blood/*drug therapy/epidemiology
Female
Follow-Up Studies
Gestational Age
Humans
Hypoglycemic Agents/*therapeutic use
Metformin/*therapeutic use
Northern Territory
Population Groups
Prediabetic State/blood/*drug therapy/epidemiology
Pregnancy
Pregnancy Outcome
Prognosis
Appears in Collections:ALIES

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.